Newbridge Financial Services Group, Inc. Aravive, Inc. Transaction History

Newbridge Financial Services Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	BUY	$3.67 - $5.8 $1,141 - $1,803	311 Added 58.68%	841 $3,000
Q1 2021 Sep 07, 2021	BUY	$5.11 - $9.24 $1,134 - $2,051	222 Added 72.08%	530 $3,000
Q3 2020 Sep 07, 2021	BUY	$4.7 - $12.06 $1,447 - $3,714	308 New	308 $1,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.